当前位置:首页 - 行情中心 - 羚锐制药(600285) - 财务分析 - 现金流量表

羚锐制药

(600285)

  

流通市值:109.16亿  总市值:109.28亿
流通股本:5.66亿   总股本:5.67亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,197,746,443.651,017,479,983.083,898,414,517.043,065,164,136.21
  收到的税费返还--775,299.8-
  收到其他与经营活动有关的现金49,411,892.1631,093,141.0226,701,559.9143,574,093.76
  经营活动现金流入小计2,247,158,335.811,048,573,124.13,925,891,376.753,108,738,229.97
  购买商品、接受劳务支付的现金352,625,671.58205,432,351.62685,446,595.1474,324,248.33
  支付给职工以及为职工支付的现金220,957,556.4896,923,725.24397,590,110.19283,353,445.18
  支付的各项税费276,655,693.42115,096,532.3534,942,951.44389,371,771.63
  支付其他与经营活动有关的现金673,579,333.8362,670,359.331,754,029,006.231,471,301,108.47
  经营活动现金流出小计1,523,818,255.28780,122,968.493,372,008,662.962,618,350,573.61
  经营活动产生的现金流量净额723,340,080.53268,450,155.61553,882,713.79490,387,656.36
二、投资活动产生的现金流量:
  收回投资收到的现金1,511,696.55-29,444,100.1623,941,820.15
  取得投资收益收到的现金34,672,836.4613,123,818.4234,008,311.5121,690,815.57
  处置固定资产、无形资产和其他长期资产收回的现金净额248,210232,0007,524,585.687,185,462
  收到的其他与投资活动有关的现金1,517,605,448.9419,166,958.91,422,341,041669,378,505.22
  投资活动现金流入小计1,554,038,191.91432,522,777.321,493,318,038.35722,196,602.94
  购建固定资产、无形资产和其他长期资产支付的现金24,471,694.1213,131,261.2356,830,201.5338,225,885.11
  投资支付的现金--20,000,00020,000,000
  取得子公司及其他营业单位支付的现金--672,549,843.75672,549,843.75
  支付其他与投资活动有关的现金1,255,000,000518,000,0001,930,064,901.681,185,703,151.68
  投资活动现金流出小计1,279,471,694.12531,131,261.232,679,444,946.961,916,478,880.54
  投资活动产生的现金流量净额274,566,497.79-98,608,483.91-1,186,126,908.61-1,194,282,277.6
三、筹资活动产生的现金流量:
  取得借款收到的现金351,860,092.8864,245,955.83371,250,790.47517,374,558.27
  收到其他与筹资活动有关的现金166,680.7---
  筹资活动现金流入小计352,026,773.5864,245,955.83371,250,790.47517,374,558.27
  偿还债务支付的现金363,910,000163,910,00070,000,00070,000,000
  分配股利、利润或偿付利息支付的现金623,935,729.0453,750511,285,617.96510,338,609.65
  支付其他与筹资活动有关的现金1,205,372.6764,8913,227,689.681,840,710.65
  筹资活动现金流出小计989,051,101.71164,028,641584,513,307.64582,179,320.3
  筹资活动产生的现金流量净额-637,024,328.13-99,782,685.17-213,262,517.17-64,804,762.03
四、汇率变动对现金及现金等价物的影响-26,748.84-9,302.68-27,150.54-22,131.92
五、现金及现金等价物净增加额360,855,501.3570,049,683.85-845,533,862.53-768,721,515.19
  加:期初现金及现金等价物余额382,843,943.47382,843,943.471,228,377,8061,228,377,806
  期末现金及现金等价物余额743,699,444.82452,893,627.32382,843,943.47459,656,290.81
补充资料:
  净利润497,854,676.89-762,447,855.85-
  资产减值准备336,588.99-608,216.19-
  固定资产和投资性房地产折旧29,537,311.67-67,874,069.54-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧29,534,930.26-67,874,069.54-
    投资性房地产折旧2,381.41---
  无形资产摊销16,020,449.57-27,343,596.37-
  长期待摊费用摊销708,440.88-2,715,390.11-
  处置固定资产、无形资产和其他长期资产的损失15,095.13--6,993,442.94-
  固定资产报废损失20,698.71-5,906,974.48-
  公允价值变动损失-2,447,389.13-7,324,507.63-
  财务费用1,255,662.83-4,142,161.02-
  投资损失-21,805,834.22--49,996,026.1-
  递延所得税-32,848,931.9-16,038,751.55-
  其中:递延所得税资产减少-29,341,868.76-14,090,973.22-
    递延所得税负债增加-3,507,063.14-1,947,778.33-
  存货的减少77,199,707.35-30,454,691.54-
  经营性应收项目的减少-160,949,898.89--202,224,745.08-
  经营性应付项目的增加301,464,777.38--147,043,558.18-
  其他3,674,798.76-26,594,843.24-
  现金的期末余额743,699,444.82-382,843,943.47-
  减:现金的期初余额382,843,943.47-1,228,377,806-
  现金及现金等价物的净增加额360,855,501.35--845,533,862.53-
公告日期2026-08-122026-04-282026-04-282025-10-30
审计意见(境内)标准无保留意见
TOP↑